City Hill Ventures

City Hill Ventures is a venture capital firm based in San Diego, California, specializing in investments within the biotechnology, cleantech, and media & entertainment sectors. Founded in 2010, the firm employs a 'venturepreneur' approach, actively founding, funding, and leading companies to maximize value and generate outsized returns. Investment sizes range from $100,000 to $20 million, reflecting the firm's commitment to supporting innovative enterprises across various stages of development.

The firm's investment strategy is characterized by its 'Found, Fund, and Lead' approach. This involves launching new companies around promising products or technologies ('Found'), investing in existing companies with strong management teams ('Fund'), and taking active operational or advisory roles in portfolio companies ('Lead'). This hands-on methodology allows City Hill Ventures to concentrate its capital and expertise on a select number of portfolio companies at a time, fostering significant growth and impact.

City Hill Ventures has demonstrated a strong track record with its first fund, achieving a Distribution to Paid-In capital (DPI) of 11 within seven years. This performance was bolstered by notable events such as Roche's merger with Ignyta and Allergan's acquisition of Bonti. Building on this success, the firm launched its second fund in 2018, expanding its focus to include cleantech and media & entertainment industries, alongside biotechnology. This evolution underscores City Hill Ventures' dedication to catalyzing global change through strategic investments in transformative sectors.